For research use only
| Cat No. | ABC-TC3838 |
| Product Type | Ocular Cells |
| Cell Type | Meshwork Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Trabecular |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Utilize Human Trabecular Meshwork Cells isolated from eye regions for glaucoma modeling, outflow regulation studies, and ophthalmic drug discovery.
Human Trabecular Meshwork Cells (HTMCs) are derived from the trabecular meshwork (TM). These cells are primarily of mesenchymal origin and exhibit heterogeneous morphology, reflecting their dynamic role in maintaining aqueous humor outflow. HTM cells display distinct ultrastructural features, such as elongated processes, abundant rough endoplasmic reticulum, and Golgi apparatus, indicative of their secretory and phagocytic functions. These cells regulate aqueous humor drainage by modulating ECM turnover and contractility, thereby maintaining intraocular pressure (IOP) homeostasis. Key molecular markers expressed by HTM cells include α-smooth muscle actin (α-SMA) and fibronectin. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | HTMC |
| Species | Human |
| Cat.No | ABC-TC3838 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Meshwork Cell |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Trabecular |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Ocular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Trabecular Meshwork Cells play a crucial role in ocular research, particularly in studying glaucoma pathogenesis and developing novel therapeutics. They are widely used in in vitro models to investigate aqueous humor outflow dynamics, ECM remodeling, and mechanotransduction pathways. They are also employed to screen IOP-lowering drugs, such as Rho kinase (ROCK) inhibitors and prostaglandin analogs, which enhance trabecular outflow facility.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).